11C- and 18F-Choline PET/MR Imaging for Prostate Cancer
Status:
Completed
Trial end date:
2015-06-30
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well 11C-choline (carbon C 11 choline) and 18F-choline
(fluorine F 18 choline) positron emission tomography/magnetic resonance (PET/MR) imaging
works in diagnosing patients with unfavorable intermediate to high-risk prostate cancer.
Diagnostic procedures, such as 11C- and 18F-choline PET/MR may help find and diagnose
prostate cancer and find out how far the disease has spread.